New Pharmaceuticals market report from Global Markets Direct: "Uni-Bio Science Group Ltd. - Product Pipeline Review - 2012"

Boston, MA -- (SBWire) -- 12/31/2012 --Global Market Direct's pharmaceuticals report, "Uni-Bio Science Group Ltd. - Product Pipeline Review - 2012" provides data on the Uni-Bio Science Group Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Uni-Bio Science Group Ltd.'s corporate website, SEC filings, investor presentations and featured press releases, both from Uni-Bio Science Group Ltd. and industry-specific third party sources, put together by Global Markets Direct's team.

View Full Report Details and Table of Contents

Scope

- Uni-Bio Science Group Ltd. - Brief Uni-Bio Science Group Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Uni-Bio Science Group Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Uni-Bio Science Group Ltd. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Uni-Bio Science Group Ltd.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get this Report

- Evaluate Uni-Bio Science Group Ltd.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Uni-Bio Science Group Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Uni-Bio Science Group Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Uni-Bio Science Group Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Uni-Bio Science Group Ltd. and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Ark Therapeutics Group plc - Product Pipeline Review - 2012
- Proximagen Group plc - Product Pipeline Review - 2012
- Simcere Pharmaceutical Group - Product Pipeline Review - 2012
- Pharming Group N.V. - Product Pipeline Review - 2012
- ProStrakan Group plc - Product Pipeline Review - 2012
- Cerebrovascular Disease - Pipeline Review, H2 2012
- OncoTherapy Science, Inc. - Product Pipeline Review - 2012
- Angelini Group - Product Pipeline Review - 2012
- Polaris Group - Product Pipeline Review - 2012
- AB Science - Product Pipeline Review - 2012